Skip to main content

Table 2 Included studies design characteristics

From: Intravenous magnesium prevents atrial fibrillation after coronary artery bypass grafting: a meta-analysis of 7 double-blind, placebo-controlled, randomized clinical trials

Author

Publication year

Country

Study design

Data collection

Sampling method

Blind

Follow-up (days)

Jadad score

Fanning et al.[23]

1991

USA

Randomized, placebo-controlled

Prospective

Consecutive

DB

4

4

Colquhoun et al.[24]

1993

UK

Randomized, placebo-controlled

Prospective

Consecutive

DB

4

4

Nurozler et al.[26]

1996

Turkey

Randomized, placebo-controlled

Prospective

Consecutive

DB

5

3

Treggiari-Venzi et al.[25]

2000

Switzerland

Randomized, placebo-controlled

NA

NA

DB

3

5

Hazelrigg et al.[21]

2004

USA

Randomized, placebo-controlled

Prospective

NA

DB

5

4

Najafi et al.[11]

2007

Iran

Randomized, placebo-controlled

Prospective

Consecutive

DB

Until AF developed and needed therapeutic intervention

4

Hamid et al.[22]

2008

Pakistan

Randomized, placebo-controlled

NA

NA

DB

1

4

  1. AF, atrial fibrillation; DB, double-blind; NA, data not available